NEJM research exhibits Pfizer's antiviral drug Paxlovid does 'little or nothing' in opposition to COVID-19 (Video)
[ A new study was published in New England Journal of Medicine (NEJM) raises serious questions over the efficacy of Pfizer's antiviral drug Paxlovid, which was previously authorized for emergency use to treat mild to moderate COVID-19 cases. Paxlovid received emergency use authorization in December 2021 as the first home treatment for COVID-19 in the … Read more